30results about How to "Medical theory is correct" patented technology

Mixed traditional Chinese medicine for treating acute leukemia is mainly formed by combining, by mass, 12 parts of gypsum, 10 parts of rhizoma anemarrhenae, 10 parts of radix rehmanniae, eight parts of rhinoceros horns, 10 parts of scrophulariae, eight parts of radix scutellariae, 15 parts of honeysuckle, 10 parts of forsythia, 10 parts of rhizoma acori graminei, eight parts of ginseng, 10 parts of rehmannia, three parts of panax notoginseng, 10 parts of deer-horn glue and 10 parts of the fruits of Chinese wolfberry. According to the mixed traditional Chinese medicine for treating the acute leukemia, heat evil accumulation, virus infection blood trouble, deficiency of both qi and yin, qi and yin tonifying and insufficiency of both the spleen and the kidney are adopted for pathologic analysis, the traditional Chinese medicine capable of clearing away heat and toxic materials, cooling blood and carrying out hemostasis, reinforcing qi and nourishing yin and tonifying the spleen and kidney are combined for treatment, the medical theory is correct, and the curative effect is stable.

The invention provides a wind-dispelling collateral-activating medicine for the demyelinating disease, belongs to the technical field of medicines, and aims at solving the problem of treating demyelinating disease. The medicine is characterized by being prepared from the following traditional Chinese medicinal materials in parts by mass: 13 parts of uncaria rhynchophylla, 6 parts of apricot kernels, 12 parts of lonicera japonica, 10 parts of dried rehamnnia roots, 10 parts of radix achyranthis bidentatae, 10 parts of silkworm excrement, 12 parts of poria cocos, 10 parts of gastrodia elata, 10 parts of astragalus membranaceus, 10 parts of angelica sinensis, 10 parts of ginseng, 10 parts of cortex phellodendri, 10 parts of rhizoma cibotii, 10 parts of semen cuscutae, 6 parts of safflower carthamus, 9 parts of earthworm, 10 parts of eucommia ulmoides, 10 parts of loranthus parasiticus and 7 parts of licorice roots. The medicine takes wind-toxin invasion, phlegm-heat stagnation and middle-qi deficiency as pathogenesis evidence, is prepared from medicine composition with effects of clearing heat, removing toxicity, tonifying qi, soothing liver, tonifying kidneys, dispelling wind, eliminating phlegm, dredging channels and collaterals and promoting blood circulation to remove stasis as the treatment medicine, and has the advantages of unique and correct theory and remarkable practical curative effect.

A combined traditional Chinese medicine treating iron deficiency anemia is mainly prepared from the following traditional Chinese medicines in parts by mass: 15 parts of radix codonopsis, 12 parts of rhizoma atractylodis macrocephalae, 10 parts of poria, 15 parts of radix angelicae sinensis, 12 parts of radix rehmanniae preparata, 12 parts of ziziphus jujuba, 10 parts of fructus psoraleae, 10 parts of deerhorn glue, 10 parts of semen cuscutae, 20 parts of semen torreyae, 10 parts of semen arecae, 10 parts of sargentgloryvine stem, 8 parts of cortex mori, and 6 parts of radix glycyrrhizae. The beneficial effects comprise that the combined traditional Chinese medicine treating iron deficiency anemia performs syndrome differentiation and treatment from four types such as qi deficiency of liver and spleen, deficiency of both heart and spleen, yang deficiency of spleen and kidney, and worm accumulation, realizes the effects of tonifying qi and fortifying spleen, tonifying qi and nourishing blood, warming and tonifying spleen and kidney, killing worm and resolving accumulation, and is correct in medical theory and substantial in practical curative effect.

The invention discloses a mixed traditional Chinese medicine for treating a chronic pulmonary heart disease. The mixed traditional Chinese medicine is prepared from the following traditional Chinese medicinal materials in parts by weight: 15 parts of purple quartz, 15 parts of magnetite, 2 parts of agilawood, 9 parts of codonopsis pilosula, 5 parts of cordyceps militaris, 6 parts of radix aconiti carmichaeli, 15 parts of prepared rhizome of rehmannia, 10 parts of the bark of white mulberry, 5 parts of ephedra, 8 parts of honeysuckle, 10 parts of dried tangerine or orange peel, and 5 parts of cinnamon. As the pathogenesis of the chronic pulmonary heart disease comprises: 1. qi deficiency of lung and kidney; 2. phlegm heat accumulated in the lung; 3. exogenous evil in the body, the mixed traditional Chinese medicine for treating the chronic pulmonary heart disease is prepared from the traditional Chinese medicinal materials capable of warming the kidney to culture vitality, collecting qi, relieving asthma, eliminating phlegm by cooling, and dispelling the wind and the toxic materials to achieve an obvious treatment effect.

The invention provides a medicine for treating breast cystic hyperplasia, belongs to the technical field of medicines, and aims to solve the problem of treating acute suppurative mastitis. The medicine is characterized by being prepared from the following traditional Chinese medicinal materials in parts by mass: 15 parts of lonicera japonica, 15 parts of dried rehamnnia roots, 13 parts of spina gleditsiae, 8 parts of pseudo-ginseng, 15 parts of cortex mori radicis, 12 parts of radix bupleuri, 15 parts of codonopsis pilosula, 12 parts of angelica sinensis, 12 parts of Chinese wolfberry fruits, 15 parts of astragalus membranaceus, 15 parts of fructus forsythiae, 10 parts of folium isatidis, 12 parts of seaweed and 8 parts of licorice roots.

The invention provides a traditional Chinese medicine composition for treating the chronic pulmonary heart disease. The composition comprises the following traditional Chinese medicines by mass: 9 parts of ginseng, 5 parts of cordyceps militaris, 6 parts of prepared monkshood, 15 parts of prepared rehmannia root, 10 parts of mulberry bark, 5 parts of ephedra stem, 8 parts of honeysuckle flower, 10 parts of dried orange peel and 10 parts of Poria cocos. The traditional Chinese medicine composition for treating the chronic pulmonary heart disease mainly uses kidney-tonifying, qi-benefiting, heat-clearing, detoxifying, antibacterial and antiphlogistic traditional Chinese medicines and has a substantial curative effect.

The invention relates to a traditional Chinese medicine composition for treating a walking corpse syndrome. The traditional Chinese medicine composition for treating a walking corpse syndrome is characterized by being prepared from the following traditional Chinese medicines in parts by weight: 10 parts of rhizoma acori graminei, 15 parts of poria cocos, 9 parts of polygala tenuifolia, 6 parts of scorpio, 12 parts of bombyx batryticatus, 10 parts of gastrodia elata, 12 parts of earthworm, 10 parts of felwort, 10 parts of akebiaquinata, 10 parts of scutellaria baicalensis, 12 parts of codonopsis pilosula, 12 parts of radix rehmanniae preparata, 10 parts of angelica sinensis, 10 parts of wolfberry seeds, 10 parts of rhizoma pinellinae praeparata and 10 parts of arisaema cum bile.

The invention discloses a traditional Chinese medicinal pill for treating epidemic encephalitis B. The traditional Chinese medicinal pill is characterized in that the pill is prepared by mixing, crushing and molding the following traditional Chinese medicinal materials in parts by weight: 6 parts of bezoar, 10 parts of forsythia, 20 parts of plaster stone, 10 parts of antelope horn, 8 parts of honeysuckle, 10 parts of radix rehmanniae, 10 parts of radix scutellariae, 15 parts of allium fistulosum, 9 parts of radix scrophulariae, 10 parts of radix curcumae, 5 parts of pig bile powder, 10 parts of smoked plum, 20 parts of oysters, and 10 parts of borneol. The traditional Chinese medicinal pill for treating epidemic encephalitis B is prepared from the traditional Chinese medicinal materials capable of clearing away heat and toxic materials, nourishing liver and kidney, and dredging collaterals, correct in the medicinal theory, convenient to take, and effective in treatment.

The invention provides a treatment drug for skin ulcers and belongs to the technical field of medicine.The treatment drug aims at solving the treatment problem of the skin ulcers.It is analyzed that the skin ulcers are caused by the fact that external bacterium and damp toxins take advantage of a weak point due to deficiency of the kidney and spleen and low immunity, blood stasis blocking is caused, and the damp toxins are latent.Traditional Chinese medicine with the effects of tonifying the kidney and spleen, dispelling wind and resolving dampness and promoting blood circulation to remove blood stasis is combined and is prepared from 15 parts of poria, 15 parts of fructus forsythiae, 15 parts of coix seeds, 15 parts of radix lsatidis, 15 parts of honeysuckle flowers, 15 parts of radix rehmanniae, 10 parts of algae, 10 parts of bighead atractylodes rhizomes, 15 parts of radix achyranthis bidentatae, 15 parts of radix scrophulariae, 10 parts of radix scutellariae, 10 parts of spina gleditsiae, 10 parts of scorpions and 7 parts of liquorice roots.The treatment drug for the skin ulcers is correct in medical theory analysis and remarkable in treatment effect.

The invention discloses pachydermoperiostosis and treating medicine thereof, and belongs to the technical filed of medicine. The histopathologic analysis and treating problems of the pachydermoperiostosis are solved. The treating medicine is characterized by being prepared from, by mass, 10 parts of ligusticum wallichii, 12 parts of radix rehmanniae preparata, 15 parts of dried rehamnnia roots, 15 parts of dimocarpus longan lour, 10 parts of fresh ginger, 12 parts of angelica sinensis, 12 parts of fructus lycii, 15 parts of red dates, 10 parts of centipedes, 10 parts of peach kernels, 15 parts of radix achyranthis bidentatae, 12 parts of fructus trichosanthis, 12 parts of poria cocos and 12 parts of sheepear inula herbs.

The invention relates to a drug for treating addisonian syndrome. The drug comprises the following traditional Chinese medicines in parts by mass: 10 parts of morindae officinalis, 9 parts of herba epimedii, 10 parts of fructus ligustri lucidi, 8 parts of astragalus membranaceus, 9 parts of monkshood, 3 parts of cinnamon, 12 parts of radix rehmanniae, 12 parts of dioscorea opposita, 9 parts of fructus corni, 12 parts of alisma, 12 parts of poria cocos, 9 parts of cortex moutan, 9 parts of fructus lycii, 30 parts of liquorice, 30 parts of dens draconis and 30 parts of magnetite.

The invention discloses soup with effects of diminishing inflammation and dredging meridian vessels for thrombophlebitis and belongs to the technical field of medicines. The soup is used for solving the treatment problem of thrombophlebitis. The preparation method mainly comprises the following steps: 1, taking the following traditional Chinese medicine materials: 15 parts of radix scrophulariae, 15 parts of oldenlandia diffusa, 15 parts of sargentodoxa cuneata, 8 parts of leech, 15 parts of the root of bidentate achyranthes, 15 parts of caulis spatholobi, 15 parts of rhizome of rehmannia, 15 parts of cinnamon, 15 parts of white paeony root, 15 parts of astragalus, 12 parts of codonopsis pilosula, 12 parts of safflower, 13 parts of herba lycopi, 12 parts of radix ophiopogonis and 8 parts of liquorice; 2, decocting the traditional Chinese medicines in clean water in an amount of 10 times that of the medicines for 30-50 minutes, and separating the residues from liquid, thereby obtaining primary liquid medicine; 3, adding a proper amount of potassium sorbate into the primary liquid medicine, and uniformly stirring; 4, cooling the primary liquid medicine obtained in the previous step to the temperature of 30-50 DEG C, distilling and concentrating to the concentration of 20-30%, thereby obtaining liquid medicine which can be directly and orally taken; and 5, filling a sterile bottle with the liquid medicine, and sealing.

The invention provides a medicine for treating poliomyelitis, belonging to the technical field of medicines, and aiming at treating poliomyelitis. The medicine is characterized by being prepared from the following traditional Chinese medicinal materials in parts by weight: 15 parts of radix clematidis, 12 parts of peach kernels, 13 parts of ramulus uncariae cum uncis, 6 parts of apricot kernels, 12 parts of honeysuckle flowers, 10 parts of radix remanniae, 10 parts of radix achyranthis bidentatae, 10 parts of silkworm excrement, 12 parts of poria cocos, 10 parts of rhizoma gastrodiae, 10 parts of radix astragali, 10 parts of radix angelica sinensis, 10 parts of radix ginseng, 10 parts of cortex phellodendri, 10 parts of rhizoma cibotii, 10 parts of semen cuscutae, 6 parts of flos carthami, 9 parts of earthworms, and 7 parts of licorice root. For the medicine for treating poliomyelitis, poliomyelitis is analyzed from the aspect of traditional Chinese medicine, at the early stage, poliomyelitis is caused by exogenous wind, damp and heat, at the later stage, the liver and the kidney are involved, consequently, quadriplegia is caused, the main causes of poliomyelitis are middle qi deficiency, wind-damp invasion, and phlegm accumulation and blood stasis, and in the aspect of treatment, the medicines with the efficacies of dispelling the wind and activating collaterals, clearing away heat and toxic materials, tonifying the liver and the kidney, and promoting blood circulation to remove blood stasis are mixed for treatment, and the effects are obvious.

The invention discloses a drug for effectively treating fetishism, and belongs to the technical field of medicine. The treatment problem of the fetishism is solved. The drug is characterized by being prepared from, by mass, 12 parts of radix gentianae, 10 parts of mung beans, 10 parts of rhizoma acori tatarinowii, 10 parts of jasmine flowers, 10 parts of tabasheer, 10 parts of inula flowers, 10 parts of christina loosestrife herb, 12 parts of honey-fried chicken gizzard membranes, 20 parts of concha margaritifera, 10 parts of white mustard seeds, 10 parts of poria with hostwood, 20 parts of iron chippings and 8 parts of licorice roots.

The invention relates to medicine for treating chronic adrenal hypofunction and relates to the technical field of medicine. The medicine aims to solve the problems that normal western medicine is not ideal in treating effect and normal traditional Chinese medicine theses taking kidney deficiency as treatment diagnosis are wrong. By means of comprehensive analysis, chronic adrenal hypofunction is caused by kidney-yang deficiency, external contraction of wind evil, wind phlegm and toxicity, qi stagnation and blood stasis, and the medicine is formed by combining traditional Chinese medicine which can invigorate the kidney and replenish essence, dispel wind-phlegm, clear heat and remove toxicity and promote blood circulation to remove blood stasis. The medicine is prepared from 15 parts of prepared aconite roots, 10 parts of rhubarb, 15 parts of semen plantaginis, 20 parts of achyranthes bidentata, 15 parts of Alocasia rhizome, 15 parts of chrysanthemums, 12 parts of dried radix rehmanniae, 12 parts of common yam rhizome, 10 parts of drynaria total flavonoids, 12 parts of herba pyrrosiae, 12 parts of radix lsatidis, 9 parts of wolfberries, 20 parts of calcined oysters, 15 parts of white mulberry root bark and 8 parts of liquorice. The medical theory is correct. As the medicine takes effect, the symptoms are lessened.

The invention relates to viral conjunctivitis and a traditional Chinese medicine for treating it, in the technical field of medicine, and solves the problem of treating viral conjunctivitis. 10 parts of Fangfeng, 15 parts of Gardenia, 10 parts of Forsythia, 8 parts of Coptis chinensis, 10 parts of Lycium barbarum, 12 parts of Achyranthes bidentata, 10 parts of Gastrodia elata, 10 parts of earthworm, 10 parts of turmeric, 10 parts of scorpion, angelica 10 servings.

The invention discloses a Chinese herbal pill used for treating bronchogenic carcinoma, belonging to the field of medical technology. The Chinese herbal pill overcomes problems in treatment of bronchogenic carcinoma. The Chinese herbal pill is characterized by being prepared from the following traditional Chinese medicines by mass through mixing: 15 parts of Radix Astragali, 15 parts of Radix Codonopsis, 15 parts of Fructus Trichosanthis, 12 parts of algae, 12 parts of sea-tangle, 15 parts of raw rehmanniae roots, 12 parts of Hedyotis diffusa, 12 parts of Semen Cuscutae, 15 parts of chicken'sgizzard membrane, 15 parts of wolfberries, 20 parts of Chinese lobelia herb, 12 parts of mustard seeds and 20 parts of chrysanthemum flowers.

The invention discloses a bone tuberculosis treatment medicine, belongs to the technical field of medicine and solves the problem about correct pathologic analysis of bone tuberculosis and combination of treatment traditional Chinese medicines into treatment medicines. The medicine is characterized by being prepared from traditional Chinese medicines in parts by mass as follows: 6 parts of potassium nitrate, 12 parts of fructus trichosanthis, 12 parts of poria cocos, 10 parts of rhizoma chuanxiong, 12 parts of radix rehmanniae praeparata, 15 parts of radix rehmanniae, 15 parts of longan pulp, 10 parts of fresh ginger, 12 parts of radix angelicae sinensis, 12 parts of fructus lycii, 15 parts of red dates, 10 parts of centipedes, 10 parts of peach kernels and 15 parts of radix achyranthis bidentatae.

A medicine for treating adrenocortical hypofunction is characterized by being composed of the following ratios of Chinese medicines: the 9 parts of cortex moutan, 9 parts of fructus corni, 10 parts ofradix achyranthis bidentatae, 9 parts of herba Epimedii, 10 parts of fructus Ligustri Lucidi, 8 parts of radix astragali, 9 parts of radix Aconiti lateralis Preparata, 3 parts of cortex Cinnamomi, 12parts of radix rehmanniae, 12 parts of rhizoma Dioscoreae, 12 parts of rhizoma Alismatis, 12 parts of Poria, 9 parts of fructus Lycii, 30 parts of radix Glycyrrhizae, 30 parts of fructus Ligustri Lucidi and 15 parts of rhizoma Phragmitis.

The invention relates to a combined traditional Chinese medicine for treating viral myocarditis. The combined traditional Chinese medicine mainly combines the following traditional Chinese medicinal materials capable of dispelling wind, removing toxic materials, dredging collaterals, soothing the nerves, reinforcing qi, nourishing blood, clearing away heat, eliminating dampness, tonifying qi, warming yang, and calming the adverse-rising energy: 8 parts of gypsum, 10 parts of cortex trichosanthis, 10 parts of the root of red-rooted salvia, 9 parts of the root of bidentate achyranthes, 6 parts of the fruit of Chinese magnoliavine, 1.5 parts of amber powder, 10 parts of honeysuckle, 10 parts of fructus forsythiae, 2 parts of cinnabar, 15 parts of herba epimedii, 3 parts of coptis chinensis, 6 parts of radix curcumae, 3 parts of leech, 10 parts of grifola, 6 parts of peach kernel, 10 parts of calcined oyster shell, and 10 parts of earthworm.

The invention relates to a traditional Chinese medicinal pill for treating Cotard syndrome, and belongs to the technical field of traditional Chinese medicine, aiming at solving the problem on treating Cotard syndrome. Upon analysis, Cotard syndrome is caused due to liver depression and qi stagnation, generation of wind as well as phlegm rising and disturbing mind upwards; therefore, the following traditional Chinese medicines, which are capable of clearing liver and relieving depression, tonifying heart and kidney, dispelling wind and clearing phlegm, and clearing heat for resuscitation, are combined: 15 parts of chlorite schist, 15 parts of peach kernel, 10 parts of salvia miltiorrhiza, 10 parts of curcuma aromatica, 12 parts of concha haliotidis, 10 parts of loofah sponge, 15 parts of chrysanthemum, 10 parts of Chinese gentian root, 10 parts of rheum officinale, 10 parts of cortex moutan, 12 parts of herba cistanche, 12 parts of fructus gardeniae, 10 parts of angelica sinensis, 10 parts of radix ophiopogonis, 10 parts of borneol and 8 parts of liquorice root; and an obtained combination is pressed into medicinal pills so as to facilitate patients to take. The traditional Chinese medicinal pill adheres to the theory of medicines and is significant in practical curative effect.

The invention relates to a traditional Chinese medicine liquid preparation for treating Meniere disease, wherein the production raw materials comprise the following traditional Chinese medicines by mass: 8 parts of gentiana scabra bunge, 10 parts of chenxianghao, 8 parts of heartleaf houttuynia herb, 7 parts of ground beetle, 12 parts of plantaginis semen, 10 parts of rhizoma pinelliae, 10 parts of gastrodia elata, 9 parts of pericarpium citri reticulatae, 10 parts of agastache rugosa, 8 parts of tuckahoe, 10 parts of concha haliotidis, 10 parts of achyranthes bidentata, 10 parts of taxillus sutchuenensis (lecomte) danser, 12 parts of ophiopogon japonicus, 10 parts of rehmannia glutinosa libosch, 10 parts of dragon's bone, and 5 parts of licorice root. The production method comprises: infiltrating the traditional Chinese medicine raw materials with water, boiling for 30 min, taking the drug liquid, and bottling to obtain the product.

The invention provides an internal and external use medicine for treating whitlow and belongs to the technical field of medicine. The medicine is used for solving the problem about treatment of whitlow. The medicine is characterized by being formed by combining an external use medicine body and an internal medicine body, wherein the external use medicine body is prepared from, by mass, 1 part of furazolidone tablet, 1 part of alum, 1 part of sulfur and 1 part of camphor, and the internal use medicine body is prepared from, by mass, 15 parts of dried radix rehmanniae, 12 parts of honeysuckle, 12 parts of fructus forsythiae, 12 parts of spina gleditsiae, 12 parts of radix achyranthis bidentatae and 7 parts of licorice root.

The invention relates to a drug for treating a spotted disease and relates to the technical field of medicine. The problem of spotted disease treatment is solved. Traditional Chinese medicine analysis suggests that the spotted disease is a representation result of the internal environment and internal factors of a human body on the outer surface of the body. From the analysis view point of traditional Chinese medicine, the spotted disease is caused by exogenous wind toxin, disharmony between Ying and Wei, wind-heat evil accumulation in the muscular striae and uniform skin moistening and nourishing, and a traditional Chinese medicine composition for dispelling the wind, reducing phlegm, clearing heat, drawing out toxin and promoting blood circulation to remove blood stasis serves as a treating traditional Chinese medicine. The drug is characterized by being prepared from, by mass, 15 parts of radix isatidis, 15 parts of caulis spatholobi, 10 parts of leech, 15 parts of radix astragali, 15 parts of radix rehmanniae, 15 parts of rhizoma alismatis, 15 parts of honeysuckle flowers, 15 parts of spina gleditsiae, 10 parts of cornu bubali, 12 parts of radix clematidis, 15 parts of codonopsis pilosula, 8 parts of cassia seeds, 15 parts of salvia miltiorrhiza and 1 part of pearl powder.

The invention relates to a compound traditional Chinese medicine for treating the Fanconi syndrome. The compound traditional Chinese medicine is based on the pathology of blood loss, deficiency of yin and yang, and liver-kidney yin deficiency, and aims at benefiting qi and nourishing blood, replenishing yang and benefiting yin, and nourishing liver and kidney. The compound traditional Chinese medicine is composed of many traditional Chinese medicine components: 5 parts of rhinoceros horns, 15 parts of lonicera japonica, 15 parts of Radix lsatidis, 10 parts of radix bupleuri, 15 parts of codonopsis pilosula, 10 parts of donkey-hide gelatin, 15 parts of rehmannia glutinosa, 10 parts of tortoise shells, 10 parts of Angelica sinensis, 10 parts of cortex lycii radicis, 15 parts of Epimedium herb, 10 parts of dodder, 6 parts of scutellaria baicalensis and 6 parts of liquorice.

The invention discloses a Chinese herbal pill used for treating bronchogenic carcinoma, belonging to the field of medical technology. The Chinese herbal pill overcomes problems in treatment of bronchogenic carcinoma. According to the results of analysis following the principles of traditional Chinese medicine, bronchogenic carcinoma is caused by co-action of wind, toxin and heat, phlegm stagnationdue to accumulating wind, qi stagnation due to blood stasis and qi binding due to phlegm stagnation; and bacteria and viruses enter from the mouth and accumulate in the lung, and hot qi ascends, so toxic qi accumulates to form tumors. A traditional Chinese medicine compound capable of clearing away heat and toxic matters, dispelling wind, reducing phlegm and activating blood circulation to dissipate blood stasis is employed and made into the Chinese herbal pill which can be conveniently taken by patients. The Chinese herbal pill is characterized by being prepared from the following traditional Chinese medicines by mass through mixing: 15 parts of Radix Astragali, 15 parts of Radix Codonopsis, 15 parts of Fructus Trichosanthis, 12 parts of algae, 12 parts of sea-tangle, 15 parts of raw rehmanniae roots, 12 parts of Hedyotis diffusa, 12 parts of Semen Cuscutae, 15 parts of chicken's gizzard membrane, 15 parts of wolfberries, 20 parts of Chinese lobelia herb, 12 parts of mustard seeds and 20 parts of chrysanthemum flowers.

The invention discloses a medicine for treating masked depression, belongs to the technical field of medicines and solves the problem of treatment of the masked depression. The medicine is prepared by combining traditional Chinese medicines including, by weight, 15 parts of dwarf lilyturf roots, 10 parts of green beans, 10 parts of tatarinowii sweetflag rhizome, 12 parts of blazed endothelium of chicken's gizzard, 20 parts of nacre, 10 parts of white mustard seeds, 10 parts of Indian bread with hostwood, 20 parts of cast iron scales, 12 parts of rough gentian and 8 parts of ural licorice roots.

The invention relates to medicine for curing claustrophobia in Chinese medicine. The medicine is combined by the following traditional Chinese medicine in parts by mass: 12 parts of dried orange peel, 15 parts of pinellia ternata, 15 parts of caulis bambusae in taeniam, 15 parts of uncaria rhynchophylla, 15 parts of radix salviae miltiorrhizae, 15 parts of nacre powder, 10 parts of selfheal, 12 parts of wild jujube, 10 parts of cortex albiziae, 15 parts of sweet flag, 12 parts of poria cocos, 10 parts of polygala tenuifolia, and 8 parts of liquorice. The inventor of the medicine analyzes claustrophobia according to traditional Chinese medicine; the claustrophobia belongs to liver depression, qi stagnation, long-time depression, fire-transmission, and mind anxiety by heat, so that a patient is easy to have lonely and panic feeling in closed space; combination treatments are conducted by traditional Chinese medicine capable of removing heat from the liver, dispelling melancholy, invigorating spleen, harmonizing stomach, eliminating phlegm by cooling, and tranquilizing by nourishing the heart; the effect is obvious.

The invention provides a medicine for treating atrial fibrillation, belonging to the technical field of medicine. The objective of the invention is to overcome problems in treatment of atrial fibrillation. Since atrial fibrillation is caused by heart-kidney yang deficiency, qi-yin insufficiency and wind-phlegm stagnation, the medicine employs traditional Chinese medicines capable of warming the kidney to remove kidney vacuity, benefiting qi, nourishing yin, calming the liver, invigorating circulation of blood, dispelling wind, reducing phlegm, soothing the channels and improving collateral circulation. The medicine comprises 15 parts of Dangshen, 15 parts of Polygonatum odoratum, 15 parts of Poria cocos, 15 parts of white draconic dentes, 20 parts of Alocasia odora, 15 parts of honeysuckle flower, 15 parts of safflower, 15 parts of Ligusticum wallichii, 10 parts of lucid ganoderma, 8 parts of wolfberry and 7 parts of licorice root. The medicine treats atrial fibrillation through combination of the traditional Chinese medicines and has substantial curative effect.

The invention relates to bantis syndromes and a therapeutic medicine thereof. The therapeutic medicine is composed of the following traditional Chinese medicines in parts by mass: 15 parts of indigowoad root, 18 parts of twotooth achyranthes root, 12 parts of rhubarb, 20 parts of honeysuckle flower, 15 parts of rehmannia root, 15 parts of tangerine peel, 10 parts of barbary wolfberry fruit, 15 parts of Chinese angelica, 20 parts of Chinese yam, 10 parts of dwarf lilyturf tuber, 10 parts of glabrous greenbrier rhizome, 15 parts of toad skin, 15 parts of milkvetch root and 15 parts of Chinese waxgourd peel. The inventor analyzes that the bantis syndromes belong to qi deficiency blood stagnation and phlegm-dampness collateral blockage and cause yin blood injuries according to traditional Chinese medicine theories, a treatment scheme of combined administration of traditional Chinese medicines with effects of reinforcing qi and nourishing blood, nourishing yin and removing heat from blood, as well as promoting blood circulation to reduce phlegm is adopted, the medical theory is correct, and the practical curative effect is significant.